Dexmedetomidine-esketamine Combined Nasal Administration and Emergence Delirium

Clinical trial NCT06566469 · COMPLETED

Trial details

NCT number: NCT06566469
Sponsor: Peking University First Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Older Patients Nasal Administration Dexmedetomidine Esketamine General Anesthesia Emergence Delirium

Start date: 2024-09-02
Primary completion: 2025-03-28
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.